Go Pro
→ CODE RED: AI Meltdown Imminent? (From Paradigm Press) (Ad)tc pixel Free SIGA Stock Alerts

Siga Technologies (SIGA) Competitors

Siga Technologies logo
$3.11 -0.04 (-1.27%)
Closing price 07/24/2026 04:00 PM Eastern
Extended Trading
$3.12 +0.01 (+0.16%)
As of 07/24/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

SIGA vs. OLMA, PURR, BIOA, JBIO, and AVTX

Should you buy Siga Technologies stock or one of its competitors? MarketBeat compares Siga Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Siga Technologies include Olema Pharmaceuticals (OLMA), Hyperliquid Strategies (PURR), BioAge Labs (BIOA), Jade Biosciences (JBIO), and Avalo Therapeutics (AVTX). These companies are all part of the "pharmaceutical products" industry.

How does Siga Technologies compare to Olema Pharmaceuticals?

Olema Pharmaceuticals (NASDAQ:OLMA) and Siga Technologies (NASDAQ:SIGA) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation, profitability and media sentiment.

Siga Technologies has higher revenue and earnings than Olema Pharmaceuticals. Olema Pharmaceuticals is trading at a lower price-to-earnings ratio than Siga Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Olema PharmaceuticalsN/AN/A-$162.45M-$2.02N/A
Siga Technologies$93.78M2.38$23.28M$0.2711.52

Olema Pharmaceuticals has a beta of 2, suggesting that its stock price is 100% more volatile than the broader market. Comparatively, Siga Technologies has a beta of 0.96, suggesting that its stock price is 4% less volatile than the broader market.

91.8% of Olema Pharmaceuticals shares are owned by institutional investors. Comparatively, 55.4% of Siga Technologies shares are owned by institutional investors. 12.6% of Olema Pharmaceuticals shares are owned by insiders. Comparatively, 2.7% of Siga Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Olema Pharmaceuticals had 5 more articles in the media than Siga Technologies. MarketBeat recorded 6 mentions for Olema Pharmaceuticals and 1 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 1.89 beat Olema Pharmaceuticals' score of 1.55 indicating that Siga Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
Olema Pharmaceuticals Very Positive
Siga Technologies Very Positive

Olema Pharmaceuticals presently has a consensus target price of $44.10, suggesting a potential upside of 276.92%. Given Olema Pharmaceuticals' stronger consensus rating and higher possible upside, equities research analysts clearly believe Olema Pharmaceuticals is more favorable than Siga Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Olema Pharmaceuticals
1 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.71
Siga Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Siga Technologies has a net margin of 21.58% compared to Olema Pharmaceuticals' net margin of 0.00%. Siga Technologies' return on equity of 10.60% beat Olema Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Olema PharmaceuticalsN/A -46.00% -41.22%
Siga Technologies 21.58%10.60%8.94%

Summary

Siga Technologies beats Olema Pharmaceuticals on 8 of the 15 factors compared between the two stocks.

How does Siga Technologies compare to Hyperliquid Strategies?

Hyperliquid Strategies (NASDAQ:PURR) and Siga Technologies (NASDAQ:SIGA) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, risk, analyst recommendations, earnings and institutional ownership.

Siga Technologies has a net margin of 21.58% compared to Hyperliquid Strategies' net margin of 0.00%. Siga Technologies' return on equity of 10.60% beat Hyperliquid Strategies' return on equity.

Company Net Margins Return on Equity Return on Assets
Hyperliquid StrategiesN/A -56.04% -52.22%
Siga Technologies 21.58%10.60%8.94%

9.4% of Hyperliquid Strategies shares are held by institutional investors. Comparatively, 55.4% of Siga Technologies shares are held by institutional investors. 8.5% of Hyperliquid Strategies shares are held by insiders. Comparatively, 2.7% of Siga Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Siga Technologies has higher revenue and earnings than Hyperliquid Strategies. Hyperliquid Strategies is trading at a lower price-to-earnings ratio than Siga Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hyperliquid Strategies$1M894.13-$16.01M-$7.37N/A
Siga Technologies$93.78M2.38$23.28M$0.2711.52

Hyperliquid Strategies has a beta of 1.66, indicating that its stock price is 66% more volatile than the broader market. Comparatively, Siga Technologies has a beta of 0.96, indicating that its stock price is 4% less volatile than the broader market.

Hyperliquid Strategies presently has a consensus price target of $12.72, suggesting a potential upside of 105.44%. Given Hyperliquid Strategies' stronger consensus rating and higher probable upside, analysts plainly believe Hyperliquid Strategies is more favorable than Siga Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hyperliquid Strategies
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Siga Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Hyperliquid Strategies had 3 more articles in the media than Siga Technologies. MarketBeat recorded 4 mentions for Hyperliquid Strategies and 1 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 1.89 beat Hyperliquid Strategies' score of 1.77 indicating that Siga Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
Hyperliquid Strategies Very Positive
Siga Technologies Very Positive

Summary

Siga Technologies beats Hyperliquid Strategies on 9 of the 16 factors compared between the two stocks.

How does Siga Technologies compare to BioAge Labs?

BioAge Labs (NASDAQ:BIOA) and Siga Technologies (NASDAQ:SIGA) are both small-cap pharmaceutical products companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings and media sentiment.

55.4% of Siga Technologies shares are owned by institutional investors. 17.6% of BioAge Labs shares are owned by company insiders. Comparatively, 2.7% of Siga Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, BioAge Labs had 2 more articles in the media than Siga Technologies. MarketBeat recorded 3 mentions for BioAge Labs and 1 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 1.89 beat BioAge Labs' score of 0.78 indicating that Siga Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
BioAge Labs Positive
Siga Technologies Very Positive

Siga Technologies has a net margin of 21.58% compared to BioAge Labs' net margin of -871.75%. Siga Technologies' return on equity of 10.60% beat BioAge Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
BioAge Labs-871.75% -29.40% -27.26%
Siga Technologies 21.58%10.60%8.94%

Siga Technologies has higher revenue and earnings than BioAge Labs. BioAge Labs is trading at a lower price-to-earnings ratio than Siga Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioAge Labs$8.99M107.64-$80.61M-$2.40N/A
Siga Technologies$93.78M2.38$23.28M$0.2711.52

BioAge Labs has a beta of 0.61, indicating that its share price is 39% less volatile than the broader market. Comparatively, Siga Technologies has a beta of 0.96, indicating that its share price is 4% less volatile than the broader market.

BioAge Labs presently has a consensus target price of $43.50, indicating a potential upside of 99.82%. Given BioAge Labs' stronger consensus rating and higher probable upside, equities analysts plainly believe BioAge Labs is more favorable than Siga Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BioAge Labs
1 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.71
Siga Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Siga Technologies beats BioAge Labs on 10 of the 16 factors compared between the two stocks.

How does Siga Technologies compare to Jade Biosciences?

Jade Biosciences (NASDAQ:JBIO) and Siga Technologies (NASDAQ:SIGA) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment.

55.4% of Siga Technologies shares are held by institutional investors. 23.1% of Jade Biosciences shares are held by company insiders. Comparatively, 2.7% of Siga Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Jade Biosciences currently has a consensus price target of $51.57, suggesting a potential upside of 156.83%. Given Jade Biosciences' stronger consensus rating and higher possible upside, research analysts plainly believe Jade Biosciences is more favorable than Siga Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jade Biosciences
1 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
2.90
Siga Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Jade Biosciences had 3 more articles in the media than Siga Technologies. MarketBeat recorded 4 mentions for Jade Biosciences and 1 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 1.89 beat Jade Biosciences' score of 1.16 indicating that Siga Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
Jade Biosciences Positive
Siga Technologies Very Positive

Siga Technologies has a net margin of 21.58% compared to Jade Biosciences' net margin of 0.00%. Siga Technologies' return on equity of 10.60% beat Jade Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Jade BiosciencesN/A -51.34% -47.32%
Siga Technologies 21.58%10.60%8.94%

Siga Technologies has higher revenue and earnings than Jade Biosciences. Jade Biosciences is trading at a lower price-to-earnings ratio than Siga Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jade BiosciencesN/AN/A-$127.41M-$2.02N/A
Siga Technologies$93.78M2.38$23.28M$0.2711.52

Jade Biosciences has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market. Comparatively, Siga Technologies has a beta of 0.96, meaning that its stock price is 4% less volatile than the broader market.

Summary

Siga Technologies beats Jade Biosciences on 9 of the 16 factors compared between the two stocks.

How does Siga Technologies compare to Avalo Therapeutics?

Siga Technologies (NASDAQ:SIGA) and Avalo Therapeutics (NASDAQ:AVTX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership.

Siga Technologies has a net margin of 21.58% compared to Avalo Therapeutics' net margin of 0.00%. Siga Technologies' return on equity of 10.60% beat Avalo Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Siga Technologies21.58% 10.60% 8.94%
Avalo Therapeutics N/A -97.54%-72.42%

Siga Technologies has a beta of 0.96, suggesting that its share price is 4% less volatile than the broader market. Comparatively, Avalo Therapeutics has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market.

55.4% of Siga Technologies shares are held by institutional investors. Comparatively, 87.1% of Avalo Therapeutics shares are held by institutional investors. 2.7% of Siga Technologies shares are held by company insiders. Comparatively, 4.5% of Avalo Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Avalo Therapeutics has a consensus target price of $45.80, suggesting a potential upside of 148.37%. Given Avalo Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Avalo Therapeutics is more favorable than Siga Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Siga Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Avalo Therapeutics
1 Sell rating(s)
0 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.86

Siga Technologies has higher revenue and earnings than Avalo Therapeutics. Avalo Therapeutics is trading at a lower price-to-earnings ratio than Siga Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Siga Technologies$93.78M2.38$23.28M$0.2711.52
Avalo Therapeutics$59K16,534.43-$78.26M-$5.46N/A

In the previous week, Avalo Therapeutics had 3 more articles in the media than Siga Technologies. MarketBeat recorded 4 mentions for Avalo Therapeutics and 1 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 1.89 beat Avalo Therapeutics' score of 0.50 indicating that Siga Technologies is being referred to more favorably in the media.

Company Overall Sentiment
Siga Technologies Very Positive
Avalo Therapeutics Neutral

Summary

Siga Technologies beats Avalo Therapeutics on 9 of the 16 factors compared between the two stocks.

Get Siga Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SIGA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SIGA vs. The Competition

Export
MetricSiga TechnologiesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$225.93M$3.07B$6.87B$12.26B
Dividend YieldN/A2.07%2.67%9.79%
P/E Ratio11.5220.2927.1423.64
Price / Sales2.38485.19517.0688.99
Price / Cash9.4627.6250.5459.64
Price / Book1.124.1310.286.07
Net Income$23.28M$65.94M$3.60B$331.99M
7 Day Performance-9.59%-4.16%-1.27%-0.63%
1 Month Performance-21.27%-3.76%-0.37%-2.00%
1 Year Performance-56.44%9.94%18.30%13.62%

Siga Technologies Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SIGA
Siga Technologies
0.714 of 5 stars		$3.11
-1.3%		N/A-55.9%$225.93M$93.78M11.5240
OLMA
Olema Pharmaceuticals
2.2813 of 5 stars		$11.61
+2.3%		$44.10
+279.9%		+156.0%$1.01BN/AN/A70
PURR
Hyperliquid Strategies
2.4122 of 5 stars		$7.01
-0.6%		$12.72
+81.5%		N/A$1.01B$1MN/AN/A
BIOA
BioAge Labs
2.6824 of 5 stars		$22.71
+1.7%		$43.50
+91.5%		+363.2%$1.01B$10.32MN/AN/A
JBIO
Jade Biosciences
3.2876 of 5 stars		$20.25
+2.9%		$51.57
+154.7%		+141.1%$999.10MN/AN/A20

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SIGA) was last updated on 7/25/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel